Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $727.2, ...

In a report released today, Asthika Goonewardene from Truist Financial maintained a Buy rating on Summit Therapeutics (SMMT – Research Report).

Truist Financial analyst Michael Ciarmoli maintained a Buy rating on Northrop Grumman (NOC – Research Report) today and set a price target of ...

Ryder System, Inc. (NYSE: R) announces that it has established a new, upsized $1.6 billion five-year corporate revolving credit facility, which includes 11 global institutions and will expire on April ...

Capital One outlined some of its to-do items as it integrates with Discover, which include long-haul investments in technology, global marketing and risk management.

Combining Trodelvy with Keytruda and pushing it into the frontline setting could “potentially double” the ADC’s market in ...

We recently published a list of 10 Best Stocks to Buy According to Billionaire Chris Rokos. In this article, we are going to ...

Chris Rokos is a highly respected British hedge fund manager who co-founded Brevan Howard Asset Management in 2002 before departing to establish his own firm in 2015, Rokos Capital Management, which ...

Truist shares offer a 5.8% dividend yield and a value opportunity with a sub-10x multiple. Click here to read why TFC stock ...

Strong cost management drives positive leverage despite a revenue dip. Read more on my updated look at the latest TFC ...

Truist Securities raised its rating on Element Solutions (NYSE:ESI) from Hold to Buy, setting a new price target of $24, down from $28, citing the company’s strong fundamentals and strategic ...

Fintel reports that on April 14, 2025, Truist Securities upgraded their outlook for Element Solutions (NYSE:ESI) from Hold to ...